The link between RAS and COVID-19 is mainly related to the role of angiotensin-converting enzyme 2 (ACE2), a central component of the RAS, as the primary binding site for SARS-CoV-2 that facilitates the virus entry into host cells [9,10]. The gene discussed is ACE2; the disease is COVID-19.